Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BCG-vaccinated cattle less infectious to other cattle, study finds
The UK government is currently conducting its own research into a deployable vaccine for cattle.
Study in Ethiopia suggests elimination of bovine TB in country is possible.

TB-infected cattle that have previously been given the Bacillus Calmette-Guérin (BCG) vaccine are less infectious to other cattle, a new study has found.
 
The research, led by the University of Cambridge and Penn State University, found that the BCG vaccine reduced TB transmission between cattle by 74 per cent per cent.

It is the first time this indirect benefit of the vaccine has been measured by scientists.

Conducted in Ethiopia, the study made use of livestock census and movement data to develop a transmission model.

Ethopia has the largest cattle population in Africa, but currently lacks a control programme for bovine TB. Intensive testing and slaughtering infected animals, as carried out in countries such as the UK, is considered to be unfeasible to implement in Ethiopia and other similar countries due to social and economic reasons.

Professor Conlan, associate professor of epidemiology at the University of Cambridge's Department of Veterinary Medicine and one of the authors of the study, said: "Results of the model suggest that vaccinating calves within the dairy sector of Ethiopia could reduce the reproduction number of the bacterium -- the R0 -- to below 1, arresting the projected increase in the burden of disease and putting herds on a pathway towards elimination of TB.”

The UK government is currently conducting its own research into creating a deployable vaccine and new DIVA skin test for bovine TB. Currently, the UK does not use the BCG vaccine because it can lead to vaccinated cattle giving false positive test results.

James Wood, Alborada professor of equine and farm animal science at the University of Cambridge's Department of Veterinary Medicine, said: "For over twenty years the UK government has pinned hopes on cattle vaccination for bovine tuberculosis as a solution to reduce the disease and the consequent costs of the controls.

“These results provide important support for the epidemiological benefit that cattle vaccination could have to reduce rates of transmission to and within herds."

The study has been published in the journal Science.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.